Nantahala Capital Management, LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Nantahala Capital Management, LLC | 184,452 7.500% | 71,910 (+63.90%) | Filing |
| 2022-02-14 08:01 am Purchase | 2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Nantahala Capital Management, LLC | 112,542 5.700% | 15,982 (+16.55%) | Filing |
| 2021-02-16 10:21 am Sale | 2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Nantahala Capital Management, LLC | 96,560 4.900% | -17,530 (-15.37%) | Filing |